Blog How can CovidSurg change practice? From scratch to the pages of the Lancet A little over 3 months ago, the CovidSurg global collaborative launched to urgently assess the safety of surgery in the unfolding coronavirus pandemic. Not long afterwards, Bowel & Cancer Research and BDRF proudly announced we would be funding the work. The first results of the study are now available and have been published in the Lancet. On 1st June, the study team hosted a webinar to discuss their findings – you can watch it below: The first set of data looks at people having surgery while infected with the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The impact of SARS-CoV-2 on postoperative pulmonary complications and mortality needs to be established in order to enable surgeons and patients to make evidence-based decisions during the pandemic. The findings show significantly increased risks, particularly in men aged 70 and over. They recommend postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery in these patients. Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. This information is critical in providing the best possible care for people who need it. Bowel cancer, IBD and other bowel diseases aren’t going anywhere – we need to know how to tackle them now. The CovidSurg team are still working and more results will be available soon. We are extremely proud to be playing our part in research to protect patients now & in future.